Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis.

ABSTRACT:

Objective

Chemerin is a novel adipokine. Previous research has investigated the association between chemerin and clinical indices in patients with obesity or metabolic syndrome (MS), although the results obtained have been inconsistent. We conducted a meta-analysis to investigate the association between chemerin and clinical indicators of diabetes, MS and obesity with obesity or MS subjects.

Design and methods

Studies were identified by searching the PubMed, the Cochrane Library, EMBASE and CNKI, databases beginning with the original report in July 2007 until the end of May 2013. For each variable, summary correlation coefficients were estimated using random-effects or fixed-effect meta-analysis with 95% confidence interval (CI) performed by STATA software.

Results

A

SUBMITTER: Li Y 

PROVIDER: S-EPMC4254750 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature